Lilly has been forced to halt phase III trials of its melanoma candidate tasisulam due to serious safety concerns over …
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations

